|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 21815500.0 (espacenet) (Federated) (European Patent Register), 20211119 | | Patent/reg. no. and date | DK/EP 4247833, 20250924 | | Publication date | 20230927 | | Priority no. and date | EP 20208556, 20201119 | | EP pub. no. and date |
EP 4247833 20230927 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | | | Inventor | ANDREAE, Fritz,
8074 RAABA-GRAMBACH, AT | | Representative | | | Opponent | | | IPC Class | C07D 257/02 (2006.01) , C07K 5/083 (2006.01) | | Title | SYNTHESIS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS | | Int. application no. | EP2021082323 | | Int. publication no. | WO2022106629 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
